Insider · CIK 0001270734

Pakianathan Deepika

CIK 0001270734 Name as filed on the most recent filing

Filed as Pakianathan Deepika (18)

53 transaction lines · from 18 filings · filed 2006-03-09 to 2024-08-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

44 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-08-22 S, Open-market sale Mereo BioPharma Group plcMREO 466,210, disposed Open Form 4 filing 0000950170-24-100281
2024-06-07 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 220,133, disposed Open Form 4 filing 0000950170-24-070991
2024-06-06 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 116,415, disposed Open Form 4 filing 0000950170-24-070991
2024-06-05 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 448,480, disposed Open Form 4 filing 0000950170-24-070991
2024-06-04 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 324,704, disposed Open Form 4 filing 0000950170-24-068969
2024-06-03 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 360,997, disposed Open Form 4 filing 0000950170-24-068969
2024-05-31 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 194,992, disposed Open Form 4 filing 0000950170-24-068969
2023-01-27 S, Open-market sale Calithera Biosciences, Inc.CALA 2 lines 46,810, disposed Open Form 4 filing 0000899243-23-003071
2022-06-10 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 7,844, disposed Open Form 4 filing 0000899243-22-021957
2022-06-09 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 1,307,028, disposed Open Form 4 filing 0000899243-22-021957
2022-06-08 S, Open-market sale Karyopharm Therapeutics Inc.KPTI 2 lines 2,119,926, disposed Open Form 4 filing 0000899243-22-021957
2016-03-23 P, Open-market purchase Senseonics Holdings, Inc.SENS 2 lines 3,500,000, acquired Open Form 4 filing 0001209191-16-110187
2015-01-12 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 2 lines 1,499,982, acquired Open Form 4 filing 0001209191-15-004180
2014-10-07 P, Open-market purchase Calithera Biosciences, Inc.CALA 2 lines 5,000,000, acquired Open Form 4 filing 0001209191-14-062661
2014-10-07 P, Open-market purchase Calithera Biosciences, Inc.CALA 2 lines 5,000,000, acquired Open Form 4 filing 0001209191-14-062753
2014-08-21 P, Open-market purchase OncoMed Pharmaceuticals IncOMED 2 lines 409,986, acquired Open Form 4 filing 0001181431-14-029918
2014-08-20 P, Open-market purchase OncoMed Pharmaceuticals IncOMED 2 lines 874,997, acquired Open Form 4 filing 0001181431-14-029918
2014-08-19 P, Open-market purchase OncoMed Pharmaceuticals IncOMED 2 lines 236,889, acquired Open Form 4 filing 0001181431-14-029918
2014-05-23 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 2 lines 46,784, acquired Open Form 4 filing 0001179110-14-009095
2014-05-22 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 2 lines 521,804, acquired Open Form 4 filing 0001179110-14-009095
2014-05-21 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 2 lines 2,426,874, acquired Open Form 4 filing 0001179110-14-009095
2014-05-13 P, Open-market purchase Alder Biopharmaceuticals IncALDR 2 lines 3,500,000, acquired Open Form 4 filing 0001209191-14-034322
2014-05-13 P, Open-market purchase Alder Biopharmaceuticals IncALDR 2 lines 3,500,000, acquired Open Form 4 filing 0001209191-14-034320
2014-04-22 P, Open-market purchase TriVascular Technologies, Inc.TRIV 9,999,996, acquired Open Form 4 filing 0000906344-14-000024
2013-11-12 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 2 lines 5,000,000, acquired Open Form 4 filing 0001104659-13-084849
2013-07-23 P, Open-market purchase OncoMed Pharmaceuticals IncOMED 2 lines 6,500,001, acquired Open Form 4 filing 0001181431-13-041153

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 23
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. PAKIANATHAN DEEPIKA, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001270734

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.